欧康医药
(920230)
| 流通市值：4.73亿 | | | 总市值：10.07亿 |
| 流通股本：4724.78万 | | | 总股本：1.00亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 201,643,782.41 | 133,151,399.95 | 55,522,438.63 | 331,737,234.49 |
| 营业总成本 | 199,426,255.81 | 131,676,010.51 | 54,401,520.85 | 317,523,106.83 |
| 其他经营收益 | | | | |
| 营业利润 | 8,305,601.19 | 5,914,209.74 | 2,657,291.73 | 12,476,485.46 |
| 利润总额 | 8,310,442.55 | 5,917,619.83 | 2,660,217.39 | 12,569,123.26 |
| 净利润 | 7,720,881.97 | 5,498,112.52 | 2,191,656.35 | 11,435,251.17 |
| 每股收益 | | | | |
| 其他综合收益 | -149,833.27 | -118,113.32 | -60,097.01 | -37,365.31 |
| 综合收益总额 | 7,571,048.7 | 5,379,999.2 | 2,131,559.34 | 11,397,885.86 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 255,809,131.38 | 254,194,445.12 | 253,694,510.5 | 261,880,362.12 |
| 非流动资产: | | | | |
| 非流动资产合计 | 255,992,901.49 | 260,295,889.77 | 266,018,534.82 | 269,702,934.83 |
| 资产总计 | 511,802,032.87 | 514,490,334.89 | 519,713,045.32 | 531,583,296.95 |
| 流动负债: | | | | |
| 流动负债合计 | 82,961,460.63 | 89,052,937.76 | 84,409,610.31 | 99,650,199.9 |
| 非流动负债: | | | | |
| 非流动负债合计 | 12,963,567.58 | 13,404,598.94 | 13,078,417.35 | 13,469,586.72 |
| 负债合计 | 95,925,028.21 | 102,457,536.7 | 97,488,027.66 | 113,119,786.62 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 415,329,344.37 | 411,443,724.74 | 421,774,208.44 | 417,987,664.98 |
| 股东权益合计 | 415,877,004.66 | 412,032,798.19 | 422,225,017.66 | 418,463,510.33 |
| 负债和股东权益合计 | 511,802,032.87 | 514,490,334.89 | 519,713,045.32 | 531,583,296.95 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 265,900,320.22 | 174,231,970.06 | 94,917,320.34 | 354,509,797.73 |
| 经营活动现金流出小计 | 243,292,372.68 | 152,855,406.85 | 67,437,362 | 347,510,910.43 |
| 经营活动产生的现金流量净额 | 22,607,947.54 | 21,376,563.21 | 27,479,958.34 | 6,998,887.3 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 226,175,764.02 | 153,143,103.78 | 11,209,811.93 | 187,810,046.72 |
| 投资活动现金流出小计 | 229,069,265.84 | 144,161,051.84 | 35,959,708.06 | 205,177,085 |
| 投资活动产生的现金流量净额 | -2,893,501.82 | 8,982,051.94 | -24,749,896.13 | -17,367,038.28 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 20,000,000 | 15,000,000 | 1,000,000 | 22,204,586.8 |
| 筹资活动现金流出小计 | 37,785,211.43 | 32,560,304.62 | 143,472.22 | 28,901,596 |
| 筹资活动产生的现金流量净额 | -17,785,211.43 | -17,560,304.62 | 856,527.78 | -6,697,009.2 |
| 汇率变动对现金及现金等价物的影响 | -243,864.99 | -200,042.48 | -269,724.71 | -115,822.79 |
| 现金及现金等价物净增加额 | 1,685,369.3 | 12,598,268.05 | 3,316,865.28 | -17,180,982.97 |
| 期末现金及现金等价物余额 | 7,315,777.03 | 18,228,675.78 | 8,947,273.01 | 5,630,407.73 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 12,598,268.05 | - | -17,180,982.97 |